Yaz is the first oral contraceptive approved for premenstrual dysphoric disorder (PMDD)

Yaz is the first oral contraceptive approved for premenstrual dysphoric disorder (PMDD).

About 5% of reproductive age women have this more severe form of premenstrual syndrome.

Yaz seems to help both physical AND emotional symptoms.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 120+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote